Sunbio Inc. (067370) Stock Forecast & Analysis
Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Sunbio Inc. (067370:KRX), powered by AI.
- Current Price
- ₩5,980
- P/E Ratio
- 26.1
- Market Cap
- 73.0B
- Sector
- Common Stock
What is the Sunbio Inc. stock price forecast?
Sunbio Inc. is currently trading at ₩5,980. View real-time AI analysis on Alpha Lenz.
What is Sunbio Inc. insider trading activity?
View the latest insider trading data for Sunbio Inc. on Alpha Lenz.
What is Sunbio Inc.'s P/E ratio?
Sunbio Inc.'s P/E ratio is 26.1.
Sunbio Inc.
KRX · 067370“Sunbio Inc. trades at a P/E of 26.1 (premium valuation) with solid ROE of 10.0%. 3Y revenue CAGR of 22.6% highlights clear growth momentum.”
Ask for details →Company Overview
Sunbio Inc. is a company involved in the biotechnology sector, specializing in the development and commercialization of pharmaceutical products and innovative solutions for the healthcare industry. Its primary function is to advance medical research and bring to market transformative therapies that address unmet medical needs. Sunbio Inc. operates in a highly dynamic and fast-evolving industry, focusing on research and development to create breakthrough treatments. Its activities impact various sectors, including drug development, clinical trials, and health technology. In the financial market, Sunbio Inc. plays a significant role as a company that investors watch for its potential to introduce new and effective medical solutions, thereby influencing biotech market trends and bringing investment opportunities to those looking to support cutting-edge healthcare advancements.
Company Statistics
FY 2025Profile
Margins
Valuation
Growth (CAGR)
Returns
Financial Health
“Sunbio Inc. trades at a P/E of 26.1 (premium valuation) with solid ROE of 10.0%. 3Y revenue CAGR of 22.6% highlights clear growth momentum.”
Ask for details →Frequently Asked Questions
Sunbio Inc. (ticker: 067370) is a company listed on KRX in the Common Stock sector (Common Stock). Market cap is $73.0B.
The current price is ₩5,980 with a P/E ratio of 26.15x and P/B of 2.53x.
ROE is 9.99% and operating margin is 36.83%. Annual revenue is $13.7B.